People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...

Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, ...

New Alzheimer's drug Leqembi offers hope to Oklahoma couple as they celebrate 50 years of marriage and fight against the ...

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate blood sugar and appetite. GLP-1 is primarily secreted from the intestines, ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than ...

Discover how certain medications can increase dementia risk by up to 50% in older adults. Learn more from University of ...

A drug maker is looking for participants for a clinical trial involving an investigational Alzheimer's drug, and Baltimore is ...